Seroprevalence of Trypanosoma cruzi in blood donors at the national blood transfusion services-Guyana

West Indian Medical Journal

Volumn 61, Issue 6, 2012, Pages

  Bwititi, P T ^a   Browne, P ^a  

^a CHARLES STURT UNIVERSITY   (Australia)

Author keywords

Blood donor screening; Chagas' disease; Enzyme Linked immunosorbent assay (ELISA); Transfusion Transmission

Indexed keywords

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CHAGAS DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GUYANA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SEROPREVALENCE;

EID: 84872576851     PISSN: 00433144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Prata A. Clinical and epidemiological aspects of Chagas' disease. Lancet Infectious Diseases 2001; 1: 92-100.
2. Moncayo A, Ortiz-Yanine MI. An update on Chagas' disease (human American trypanosomiasis). Annals of Tropical Med Parasitol 2006; 100: 1-15.
3. Pan American Health Organization (PAHO). Epidemiological profiles for neglected diseases and other infections related to poverty in Latin America and the Caribbean, consultation on a Latin America and Caribbean trust fund for the prevention, control, and elimination of neglected and other infectious diseases. Washington, DC: PAHO; 2008.
4. World Health Organization (WHO). Control of Chagas' disease. Report of a WHO Expert Committee. WHO Technical Report Series 811. Geneva: WHO; 1991.
5. World Health Organization. Control of Chagas' disease. Second Report of the WHO Expert Committee. WHO Technical Report Series 905. Geneva: WHO; 2002.
6. Schmunis GA. Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz 2007; 102 (Suppl 1): 75-85.
7. Strosberg AM, Barrio K, Stinger VH, Tashker J, Wilbur JC, Wilson L et al. Chagas Disease: a Latin American nemesis. San Francisco, CA: Institute of One World Health; 2007: 1-110.
8. Benchimol BPR. The oral transmission of Chagas' disease: an acute form of infection responsible for regional outbreaks. Int J Cardiol 2006; 112: 132-3.
9. Torrico F, Alonso-Vega C, Suarez E, Rodriguez P, Torrico MC, Dramaix M et al. Maternal Trypanosoma cruzi infection, pregnancy outcome, morbidity and mortality of congenitally infected and non-infected newborns in Bolivia. Am J Trop Med Hyg 2004; 70: 201-9.
10. Moraes-Souza H. Chagas Infection transmission control: situation of transfusional transmission in Brazil and other countries of Latin America. Mem Inst Oswaldo Cruz 1999; 94 (Suppl 1): 419-23.
11. Wendel S. Current concepts on the transmission of bacteria and parasite by blood components. São Paulo Med J 1995; 113: 1036-52.
12. Schmunis GA. Trypanosoma cruzi, the aetiologic agent of Chagas' disease: status in the blood supply in endemic and non-endemic countries. Transfusion 1991; 31: 547-57.
13. Teixeira ARL, Nacimento RJ, Strum NR. Evolution and pathology in Chagas disease - a review. Mem Inst Oswaldo Cruz 2006; 101: 463-91.
14. Von A, Zaragoza L, Jones D, Rodríguez-Morales AJ, Franco-Paredes C. New insights into Chagas disease: a neglected disease in Latin America. J Infections Devel Countries 2007; 1: 99-111.
15. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL, eds. Global burden of disease and risk factors. New York/Washington DC: Oxford University Press and World Bank, 2006: 144.
16. Carvalho MR. Krieger MA, Almeida E. Chagas' disease diagnosis: evaluation of several tests in blood bank screening. Transfusion 1993; 33: 830-4.
17. Rawlins C, Baboolal S, Parsad K, Charles W, Twari T, Hardy L et al. The prevalence of antibodies to Trypanosoma cruzi in Guyana, Suriname and Trinidad and Tobago. Suriname Med Bull 2001; 16: 25-35.
18. Rambadjan I. The first autochthonous case of Chagas disease with notes on possible vectors in Guyana. Tropical Geo Med 1984; 36: 73-6.
19. rd Edition. St Augustine, Trinidad and Tobago: CHRC; 2003.
20. Aché A, Matos AJ. Interrupting Chagas' disease transmission in Venezuela. Rev Inst Med Trop de São Paulo 2001; 43: 37-43.
21. Moraes-Souza H. Chagas infection transmission control: situation of transfusional transmission in Brazil and other countries of Latin America. Mem Inst Oswaldo Cruz 1999; 94 (Suppl 1): 419-23.
22. Guyana Bureau of Statistics. Preliminary report of population and housing census; 2002.
23. Schmunis GA, Zicker F, Pinheiro F, Brandling-Bennett D. Risk of transfusion-transmitted infectious diseases in Latin America. Emerg Infectious Dis 1998; 4: 5-11.
24. Cruz JR, Perez-Rosales MD. Availability, safety, and quality of blood for transfusion in the Americas. Rev Panam Salud Publica 2003; 13: 103-10.
25. ABB. Association Bulletin #06-08. Information concerning implementation of a licensed test for antibodies to T cruzi; 2006. Available from: http://www.aabb.org/Documents/Members_Area/Association_Bulletins/ab06-08.pdf
26. Hamerschlak N, Pasternak J, Neto VA, de Carvalho MB, Guerra CS, Coscina AL et al. Chagas' disease: an algorithm for donor screening and positive donor counseling. Rev Soc Bras Med Trop 1997; 30: 205-9.
27. Castro E. Chagas' disease: lessons from routine donation testing. Transfusion Med 2009; 19: 16-23.